Christine Blank
Contributing Editor Christine Blank is a freelance writer based in Florida.
Why 2016 drug approvals fell
Why 2016 drug approvals fell
While FDA approved far fewer new drugs in 2016 than 2015, the agency quickly approved novel and breakthrough therapies.
Advanced ovarian cancer drug approved
FDA recently approved rucaparib (Rubraca, Clovis Oncology) tablets to treat patients with deleterious BRCA mutation (germline and/or somatic)-associated advanced ovarian cancer, who have been treated with 2 or more chemotherapies.
FDA green lights first treatment for rare spinal disease
FDA approved nusinersen (Spinraza, Biogen), the first drug to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
New diabetes combo drug available soon
A new combination drug for type 2 diabetes will available in the US in the coming months.
FDA issues warnings over anesthesia, diabetes drugs
FDA issued two important drug warnings this week: one linking certain diabetes medications to bladder cancer and another about the use of general anesthetic and sedation drugs during pregnancy.
FDA approves expansion of Avastin in ovarian cancer
FDA recently approved bevacizumab (Avastin, Genentech) for patients with platinum-sensitive recurrent epithelial ovarian (psOC), fallopian tube or primary peritoneal cancer.
US drug spending predicted to drop
US drug spending predicted to drop
The US growth rate for spending on medicines is expected to fall in 2016 and beyond, according to new research.
Analyst: CVS’ OptumRx deal amps up competition
Last month, OptumRx and CVS Pharmacy announced that they are partnering to provide more convenient choices and lower costs for patients.
Are states going too far with painkiller script limits?
Arizona has become the latest state to limit opioid prescriptions—a trend that has some healthcare providers and experts concerned.
New COPD guidelines tout bronchodilators and antibiotics
Use inhaled corticosteroids sparingly and only in these circumstances in patients with COPD. Details here.

Poll

View Results